|
Erythropoietin-Derived Short Peptide and Its Mimics as Immuno/Inflammatory Modulators
Invention Summary:
Erythropoeitin (Epo) is a hematopoietic growth factor widely used in the treatment of anemia and has been claimed to have direct neuroprotective effects. However, long-term Epo therapy can lead to the excessive elevation of platelets and red blood cells in non-anemic individuals. A short Epo-derived peptide has recently been shown...
Published: 5/9/2024
|
Inventor(s): Rui Rong Yuan, Peter Dowling, Bo Wang, Wei Lu
Keywords(s): Neurological disorder & neuropathic pain
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics
|
